Skip to main content

Watson 369 5 mg Pill - white capsule/oblong, 18mm

Pill with imprint Watson 369 5 mg is White, Capsule/Oblong and has been identified as Loxapine Succinate 5 mg. It is supplied by Watson Laboratories, Inc.

Loxapine is used in the treatment of Agitated State; Agitation; Schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 369 5 mg

Loxapine succinate 5 mg Watson 369 5 mg
Loxapine succinate 5 mg Watson 369 5 mg
Loxapine succinate 5 mg Watson 369 5 mg

Loxapine Succinate

Watson 369 5 mg
5 mg
18.00 mm
Prescription only
Drug Class
Miscellaneous antipsychotic agents
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose anhydrous, benzyl alcohol, butylparaben, edetate calcium disodium, gelatin, magnesium stearate, methylparaben, polacrilin potassium, propylparaben, sodium lauryl sulfate, sodium propionate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.